(EDEN) Edenred - Overview
Sector: Financial Services | Industry: Credit Services | Exchange: PA (France) | Market Cap: 4.227m EUR | Total Return: -33.7% in 12m
Employee Benefits, Mobility, Payments
Total Rating 41
Safety 59
Buy Signal 0.05
Credit Services
Industry Rotation: +1.9
Industry Rotation: +1.9
Market Cap:
4.93B
Avg Turnover: 16.1M EUR
Avg Turnover: 16.1M EUR
ATR:
4.53%
Peers RS (IBD): 34.2
Peers RS (IBD): 34.2
Risk 5d forecast
Volatility44.7%
Rel. Tail Risk-12.3%
Reward TTM
Sharpe Ratio-0.82
Alpha-50.23
Character TTM
Beta0.307
Beta Downside0.664
Drawdowns 3y
Max DD73.38%
CAGR/Max DD-0.42
Warnings
Choppy
Tailwinds
No distinct edge detected
Description: EDEN Edenred
Edenred SE (ticker EDEN) is a French-based digital platform that delivers employee benefit, mobility, and complementary payment solutions to corporations, workers, and merchants worldwide. Its portfolio spans meal-voucher programs such as Ticket Restaurant and Ticket Alimentación, gift-voucher and cultural-goods offerings, as well as fuel-card, fleet-management, and electric-vehicle-charging services like Spirii.
In FY 2023 Edenred generated €6.0 billion in revenue, up 4.2 % YoY, with an EBITDA margin of roughly 15 % and net profit margin of 5.5 %. The Q1 2024 results showed a further 5 % revenue increase, driven by strong adoption of its digital ticketing solutions and expanding demand for sustainable-focused products such as EcoCheque, which benefits from EU green-spending incentives. The company’s growth is also supported by macro-trends like rising corporate spending on employee well-being and the broader shift toward cash-less, cloud-based payment platforms in the diversified support services sector.
For a deeper dive, see the ValueRay analysis of EDEN.
- Employee benefit solution adoption drives recurring revenue growth
- Mobility solution expansion increases market share
- Regulatory changes impact digital payment platform profitability
- Economic downturns reduce corporate spending on employee benefits
- Competition from fintech platforms pressures pricing and margins
Piotroski VR‑10 (Strict)
7.0
| Net Income: 1.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.28 > 1.0 |
| NWC/Revenue: -7.38% < 20% (prev -21.77%; Δ 14.40% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.96b > Net Income 1.03b |
| Net Debt (-420.0m) to EBITDA (2.34b): -0.18 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.4m) vs 12m ago -16.40% < -2% |
| Gross Margin: 49.32% > 18% (prev 0.54%; Δ 4.88k% > 0.5%) |
| Asset Turnover: 39.76% > 50% (prev 28.36%; Δ 11.40% > 0%) |
| Interest Coverage Ratio: 5.85 > 6 (EBITDA TTM 2.34b / Interest Expense TTM 316.0m) |
Altman Z''
0.24
| A: -0.03 (Total Current Assets 8.86b - Total Current Liabilities 9.25b) / Total Assets 13.57b |
| B: -0.12 (Retained Earnings -1.57b / Total Assets 13.57b) |
| C: 0.14 (EBIT TTM 1.85b / Avg Total Assets 13.43b) |
| D: -0.11 (Book Value of Equity -1.57b / Total Liabilities 14.39b) |
| Altman-Z'' Score: 0.24 = B |
Beneish M
-3.24
| DSRI: 0.31 (Receivables 1.46b/3.36b, Revenue 5.34b/3.77b) |
| GMI: 1.10 (GM 49.32% / 54.43%) |
| AQI: 1.05 (AQ_t 0.34 / AQ_t-1 0.32) |
| SGI: 1.42 (Revenue 5.34b / 3.77b) |
| TATA: -0.07 (NI 1.03b - CFO 1.96b) / TA 13.57b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of EDEN shares?
As of April 10, 2026, the stock is trading at EUR 18.10 with a total of 810,433 shares traded.
Over the past week, the price has changed by +5.70%, over one month by -3.36%, over three months by -2.77% and over the past year by -33.70%.
Over the past week, the price has changed by +5.70%, over one month by -3.36%, over three months by -2.77% and over the past year by -33.70%.
Is EDEN a buy, sell or hold?
Edenred has no consensus analysts rating.
What are the forecasts/targets for the EDEN price?
| Analysts Target Price | - | - |
Edenred (EDEN) - Fundamental Data Overview
as of 10 April 2026
Market Cap USD = 4.93b (4.23b EUR * 1.1659 EUR.USD)P/E Trailing = 8.5212
P/E Forward = 7.764
P/S = 1.5471
P/EG = 1.1252
Revenue TTM = 5.34b EUR
EBIT TTM = 1.85b EUR
EBITDA TTM = 2.34b EUR
Long Term Debt = 3.38b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.12b EUR (from shortLongTermDebt, last quarter)
Debt = 4.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -420.0m EUR (from netDebt column, last quarter)
Enterprise Value = 3.81b EUR (4.23b + Debt 4.83b - CCE 5.25b)
Interest Coverage Ratio = 5.85 (Ebit TTM 1.85b / Interest Expense TTM 316.0m)
EV/FCF = 2.32x (Enterprise Value 3.81b / FCF TTM 1.64b)
FCF Yield = 43.16% (FCF TTM 1.64b / Enterprise Value 3.81b)
FCF Margin = 30.76% (FCF TTM 1.64b / Revenue TTM 5.34b)
Net Margin = 19.25% (Net Income TTM 1.03b / Revenue TTM 5.34b)
Gross Margin = 49.32% ((Revenue TTM 5.34b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 61.59% (prev 42.87%)
Tobins Q-Ratio = 0.28 (Enterprise Value 3.81b / Total Assets 13.57b)
Interest Expense / Debt = 2.36% (Interest Expense 114.0m / Debt 4.83b)
Taxrate = 30.18% (134.0m / 444.0m)
NOPAT = 1.29b (EBIT 1.85b * (1 - 30.18%))
Current Ratio = 0.96 (Total Current Assets 8.86b / Total Current Liabilities 9.25b)
Debt / Equity = -5.90 (negative equity) (Debt 4.83b / totalStockholderEquity, last quarter -818.0m)
Debt / EBITDA = -0.18 (Net Debt -420.0m / EBITDA 2.34b)
Debt / FCF = -0.26 (Net Debt -420.0m / FCF TTM 1.64b)
Total Stockholder Equity = -956.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.65% (Net Income 1.03b / Total Assets 13.57b)
RoE = -107.5% (negative equity) (Net Income TTM 1.03b / Total Stockholder Equity -956.5m)
RoCE = 76.18% (EBIT 1.85b / Capital Employed (Equity -956.5m + L.T.Debt 3.38b))
RoIC = 35.33% (NOPAT 1.29b / Invested Capital 3.66b)
WACC = 4.18% (E(4.23b)/V(9.05b) * Re(7.06%) + D(4.83b)/V(9.05b) * Rd(2.36%) * (1-Tc(0.30)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -8.56%
[DCF] Terminal Value 88.44% ; FCFF base≈1.40b ; Y1≈1.73b ; Y5≈2.95b
[DCF] Fair Price = 367.8 (EV 85.63b - Net Debt -420.0m = Equity 86.05b / Shares 234.0m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 8.12 | EPS CAGR: -51.81% | SUE: 0.0 | # QB: 0
Revenue Correlation: 74.72 | Revenue CAGR: 50.73% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.08 | Chg7d=-0.021 | Chg30d=-0.063 | Revisions Net=-3 | Growth EPS=-19.7% | Growth Revenue=-1.8%
EPS next Year (2027-12-31): EPS=2.37 | Chg7d=+0.005 | Chg30d=-0.034 | Revisions Net=+2 | Growth EPS=+13.9% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: -0.33 (3 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -3.8% (Discount Rate 7.9% - Earnings Yield 11.7%)
[Growth] Growth Spread = +10.4% (Analyst 6.6% - Implied -3.8%)